Empyrean Capital Partners, LP Ashland Global Holdings Inc Transaction History

Empyrean Capital Partners, LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$93.6 - $113.62 $19.7 Million - $23.9 Million	-210,049 Reduced 24.26%	655,918 $70.5 Million
Q2 2022 Aug 15, 2022	SELL	$94.81 - $110.51 $24.1 Million - $28.1 Million	-254,452 Reduced 22.71%	865,967 $89.2 Million
Q3 2021 Nov 15, 2021	BUY	$82.47 - $93.93 $11.4 Million - $13 Million	138,022 Added 14.05%	1,120,419 $99.9 Million
Q4 2020 Feb 16, 2021	BUY	$68.68 - $81.59 $3.2 Million - $3.8 Million	46,600 Added 4.98%	982,397 $77.8 Million
Q3 2020 Nov 16, 2020	BUY	$67.37 - $79.65 $27.9 Million - $33 Million	414,439 Added 79.49%	935,797 $66.4 Million
Q2 2020 Aug 14, 2020	SELL	$46.91 - $73.98 $556,352 - $877,402	-11,860 Reduced 2.22%	521,358 $36 Million
Q1 2020 May 15, 2020	BUY	$39.76 - $81.31 $21.2 Million - $43.4 Million	533,218 New	533,218 $26.7 Million
Q4 2019 Feb 14, 2020	SELL	$71.59 - $78.85 $106 Million - $117 Million	-1,485,000 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$70.86 - $80.43 $25.5 Million - $28.9 Million	-359,340 Reduced 19.48%	1,485,000 $114 Million
Q2 2019 Aug 14, 2019	BUY	$71.31 - $80.53 $16 Million - $18 Million	224,000 Added 13.82%	1,844,340 $147 Million
Q1 2019 May 15, 2019	BUY	$69.3 - $79.5 $30.7 Million - $35.2 Million	443,150 Added 37.64%	1,620,340 $127 Million
Q4 2018 Feb 14, 2019	BUY	$65.28 - $84.21 $28.1 Million - $36.2 Million	430,000 Added 57.55%	1,177,190 $83.5 Million
Q3 2018 Nov 14, 2018	BUY	$77.93 - $86.11 $58.2 Million - $64.3 Million	747,190 New	747,190 $62.7 Million

389

42.7M

38.5K

223K

Ticker ASH
Exchange NYSE
Sector Basic Materials
Industry Specialty Chemicals
Shares Outstandng 54,139,400
Market Cap $3.47B
Description
Ashland Inc. provides additives and specialty ingredients worldwide. It operates through Life Sciences; Personal Care & Household; Specialty Additives; and Intermediates and Solvents segments. The Life Sciences segment offers pharmaceutical solutions, including controlled release polymers, disintegrants, tablet coatings, thickeners, solubili...

Get notified when there are updates to the investment portfolio of Empyrean Capital Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Empyrean Capital Partners, LP with notifications on news.